DOMAIN
|
Competency Standard
|
| 1. | Conduct testing and diagnosis of HIV |
|
| 1.1 | Understand and perform various HIV testing options. |
| 1.2 | Understand and perform CD4 Testing. |
| 1.3 | Conduct Pharmacist-Initiated Counselling and Testing (PhICT). |
| 1.4 | Provide Risk Reduction Counselling. |
| 1.5 | Use immunological and virological parameters in understanding the severity of HIV infection. |
|
| 2. | Initiate pre-exposure prophylaxis (PrEP), post-exposure prophylaxis (PEP) and 1st line antiretroviral therapy (ART) plus the initiation of TB-preventative therapy (TPT) where appropriate and apply protocol adherence measures |
|
| 2.1 | Demonstrate knowledge of ART Principles. |
| 2.2 | Prepare patients for ART adherence. |
| 2.3 | Identify, classify, and analyse the various types of ARTs and their side effects and toxicities. |
| 2.5 | Analyse ART medicine choices in PrEP and PEP, and considerations around pharmacology and drug interactions, including TPT. |
| 2.6 | Identify and manage PrEP, PEP and ART contra-indications. |
| 2.7 | Conduct PEP in the PIMART environment. |
|
| 3. | Implement processes for the prevention of HIV transmission and infection via PrEP, safer conception and contraception, and prevention of mother to child transmission (PMTCT) |
|
| 3.1 | Implement PrEP in the PIMART environment. |
| 3.2 | Conduct pregnancy screening and recommend contraception in the PIMART context. |
| 3.3 | Implement pre-conception management for HIV positive couples. |
| 3.4 | Demonstrate knowledge of PMTCT and the rationale for PMTCT programmes. |
|
| 4. | Implement processes to identify and manage co-morbidities and opportunistic infections related to HIV |
|
| 4.1 | Manage HIV co-morbidities. |
| 4.2 | Identify and manage common opportunistic infections. |
| 4.3 | Manage TB and HIV co-infection. |
| 4.4 | Promote TB prevention. |
|
| 5. | Implement processes to prevent and manage drug interactions and drug resistance |
|
| 5.1 | Understand the importance of drug interactions, e.g. drug/drug and drug/disease. |
| 5.2 | Demonstrate in-depth knowledge of various ART drug interactions. |
| 5.3 | Prevent adverse drug interactions and reactions. |
| 5.4 | Define the types and consequences of drug resistance. |
|
| 6. | Handle ART data responsibly and use disease management systems appropriately |
|
| 6.1 | Generate reports to assist with clinical governance, programme management and quality improvement. |
| 6.2 | Use a Patient Management System. |
| 6.3 | Implement the process of care for PIMART. |
| 6.4 | Apply minimum package of interventions to support linkage to care. |
|